The bacterial lac Z gene (also known as β -galactosidase or β -gal) is often used as an indicator gene in gene transfer experiments. This marker gene facilitates analyses since the expression of the β -gal gene product can easily be assayed, and a positive result indicates that gene transfer and expression were successful. Expression of β -gal can be analyzed as enzymatic activity in a number of ways including histochemical staining of fixed cells (2, 7) , fluorescence-activated cell sorting (6) or the highly sensitive measurement of emission of light from a photoemitting substrate (4) . The latter method is particularly useful because it is quantitative.
A murine leukemia virus (MLV)-derived retroviral vector (BAG) carrying the β -gal gene under the transcriptional control of the MLV promoter ( Figure 1 ) (7) is routinely used in our laboratory to assess gene transfer efficiency (8) . In preliminary experiments, we sought to assess gene transfer efficiency to arteries (smooth muscle cells) in a pig model for re-stenosis, a proliferative disorder that arises as a result of physical removal of plaque material from the artery wall (1). The BAG plasmid was lipofected, using LIPOFECT AMINE ™ (Life Technologies, Eggenstein, Germany) onto the inner lumen wall of porcine arteries. It could be demonstrated that the treated arteries had acquired the BAG DNA by both Southern blotting (not shown) and polymerase chain reaction (PCR) ( Figure 1 , lanes 2, 6, 10 and 12). The treated artery samples were analyzed for β -gal expression at various times after lipofection. Although occasional blue cells could be detected after histochemical staining with 5-bromo-4-chloro-3-indolyl-β -Dgalactoside (X-gal) (ca. 1 in 1000 cells), expression of β -gal could not be detected in a highly sensitive light emission assay, Galacto-Light ™ β -galactosidase assay (Tropix, Bedford, MA, USA) using artery extracts prepared according to the manufacturers instructions ( Figure 2C ). Various modifications to the protein extraction protocol had no obvious influence on β -gal expression, and the lack of detectable β -gal expression was also not due to the pH of the artery extract since this was not significantly different from that of cell extracts showing β -gal expression (not shown).
The lack of detectable β -gal expression is probably not due to the inability of the smooth muscle cells to express the construct since lipofection (or infection with BAG retroviral vector 78BioTechniques
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Figure1. PCR analysis. Panel A shows a diagrammatic representation of the plasmid pBAG (7), which carries an MLV-derived vector carrying the β -gal gene under the transcriptional control of the MLV promoter. Indicated by arrows are two primers used for PCR analysis (485 and 2296 bps, referring to their location in the MLV vector), as is the Hpa I β -gal-specific DNA fragment used as a hybridization probe (checkered box). Panel B shows the results of a PCR analysis performed using this primer pair on genomic DNA isolated from lipofected (lanes 2, 6, 10 and 12), non-lipofected (lanes 3-5,7-9) arteries or pBAG plasmid DNA (lane 1) and hybridized to the β -gal specific probe. As expected, the pBAG lipofected arteries show a 1812-bp β -gal-specific PCR product.
particles) of primary porcine cells gave easily detectable β -gal expression (Figure 2A) , even in the less sensitive histochemical staining assay (not shown). Also other groups have not reported difficulties in expressing other genes in similar animal models for restenosis (5) . Taken together, these observations suggested that the artery extract may itself extinguish β -gal expression. To determine if this was the case, extracts from porcine or murine arteries that had not been lipofected (or infected) were isolated. Briefly, 4-mm sections through the artery, forming a ring of material, were prepared, frozen in liquid nitrogen and then homogenized and resuspended in the lysis buffer provided in the Tropix kit. The resultant artery extracts were then mixed with purified β -gal protein (Sigma Chemical, Munich, Germany). The enzymatic activity of the purified β -gal (Figure 3 , Panel A, curve A) was reproducibly reduced to less than 1% by the porcine (Figure 3 , Panel A, curve B) and murine ( Figure 3 , Panel A, curve C) artery extracts, but not by extracts from cell lines, suggesting that the extract contains an expression inhibitor.
Pretreatment of the extract with Chelex ® -100 (Bio-Rad, Hercules, CA, USA) (Figure 3, Panel B, curve B) , which removes divalent cations, reduces the ability of the artery extract to interfere with β -gal activity (Figure 3 , Panel B, curve B compared with curve C). This suggests that the inhibitor either requires a divalent cation for optimal activity or that a divalent cation directly interferes with β -gal enzymatic activity.
The β -gal gene has often been used in promoter analysis experiments in vivo, for example in transgenic mice (3) . The finding that arteries contain an inhibitor of this enzymatic activity will be particularly important when smooth muscle cell specific promoters, of potential use in gene therapy to direct the expression of linked therapeutic genes, are analyzed, since either other marker genes must be used or cell extracts must be pretreated with a chelating agent. A second concern is that extracts from other tissues may also contain inhibitors of β -gal enzyme activity, which may be misinterpreted as an inability of a promoter to give expression in these tissues. 
